Case-Matched Comparison of Functional and Quality of Life Outcomes of Local Excision and Total Mesorectal Excision Following Chemoradiotherapy for Rectal Cancer

被引:8
作者
Brachet, Suzanne [1 ]
Meillat, Helene [1 ,6 ]
Chanez, Brice [1 ]
Ratone, Jean-Philippe [2 ]
Brunelle, Serge [3 ]
Tyran, Marguerite [4 ]
Poizat, Flora [5 ]
de Chaisemartin, Cecile [1 ]
Lelong, Bernard [1 ]
机构
[1] Inst Paoli Calmettes, Dept Digest Surg Oncol, Marseille, France
[2] Inst Paoli Calmettes, Dept Digest Endoscopy, Marseille, France
[3] Inst Paoli Calmettes, Dept Radiol, Marseille, France
[4] Inst Paoli Calmettes, Dept Radiotherapy, Marseille, France
[5] Inst Paoli Calmettes, Dept Pathol, Marseille, France
[6] Inst Paoli Calmettes, Dept Digest Surg Oncol, 232 Blvd Sainte Marguer, Marseille, France
关键词
Bowel dysfunction; Chemoradiotherapy; Local excision; Mesorectal excision; Quality of life; Rectal cancer; TRANSANAL ENDOSCOPIC MICROSURGERY; FUNCTION INDEX FSFI; PREOPERATIVE RADIOTHERAPY; ORGAN PRESERVATION; NEOADJUVANT CHEMORADIOTHERAPY; PSYCHOMETRIC VALIDATION; SEXUAL DYSFUNCTION; BOWEL DYSFUNCTION; OPEN-LABEL; GRECCAR;
D O I
10.1097/DCR.0000000000002384
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
BACKGROUND: Neoadjuvant chemoradiotherapy followed by radical surgery is the standard curative treatment for mid- to low-rectal cancer. However, the combination of these treatments may affect patients' GI and genitourinary functions and their quality of life. In the cases of good clinical response to neoadjuvant treatment, local excision is a rectal sparing strategy that would limit these side effects. OBJECTIVE: The aim of this study is to compare the effects of local excision or conventional laparoscopic total mesorectal excision after chemoradiotherapy in patients with rectal cancer. DESIGN: The design is a retrospective study. SETTING: The setting used is a single tertiary center. PATIENTS: Patients with mid- to low-rectal cancer treated with chemoradiotherapy and accessible via conservative surgery at our hospital between January 2010 and December 2018 were included. Patients undergoing local excision were matched 1 to 1 with the patients undergoing total mesorectal excision by age, sex, body mass index, tumor height, and year of surgery. MAIN OUTCOME MEASURES: Quality of life and digestive and genitourinary functions were measured using validated questionnaires. The socioeconomic impact was also assessed. RESULTS: Forty-four patients undergoing local excision agreed to participate and were matched with 44 patients undergoing total mesorectal excision. Patients who underwent local excision reported a more favorable global health status (p < 0.01), emotional function (p = 0.035), social function (p = 0.04), and body image (p = 0.04). The low anterior resection syndrome score (rate of major syndrome, 23.8% vs 54.5%; p < 0.01) and the specific fecal incontinence subscale score (p < 0.01) were more favorable in the local excision group. Sexual and urinary outcomes were comparable between the 2 groups. Local excision had a lower impact on the professional status (35.7% vs 76.5%; p = 0.03). LIMITATIONS: The study limitations include its retrospective design and small sample size. CONCLUSIONS: When indicated, local excision improves the bowel function and quality of life of patients undergoing surgery for rectal cancer after chemoradiotherapy compared with total mesorectal excision.
引用
收藏
页码:1464 / 1474
页数:11
相关论文
共 39 条
[1]   THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].
AARONSON, NK ;
AHMEDZAI, S ;
BERGMAN, B ;
BULLINGER, M ;
CULL, A ;
DUEZ, NJ ;
FILIBERTI, A ;
FLECHTNER, H ;
FLEISHMAN, SB ;
DEHAES, JCJM ;
KAASA, S ;
KLEE, M ;
OSOBA, D ;
RAZAVI, D ;
ROFE, PB ;
SCHRAUB, S ;
SNEEUW, K ;
SULLIVAN, M ;
TAKEDA, F .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376
[2]  
Amin MB., 2017, AJCC CANC STAGING MA, V8th, P20
[3]  
[Anonymous], 2024, Optimisation of Response for Organ Preservation in Rectal Cancer: Neoadjuvant Chemotherapy and Radiochemotherapy vs. Radiochemotherapy (GRECCAR12)
[4]  
[Anonymous], SAF BOOST CXB EBRT C
[5]   Psychometric validation of the female sexual function index (FSFI) in cancer survivors [J].
Baser, Raymond E. ;
Li, Yuelin ;
Carter, Jeanne .
CANCER, 2012, 118 (18) :4606-4618
[6]   Improving quality of life after treatment for rectal cancer [J].
Beets, Geerard .
LANCET, 2017, 390 (10093) :432-434
[7]   Multilingual translation of the functional assessment of cancer therapy (FACT) quality of life measurement system [J].
Bonomi, AE ;
Cella, DF ;
Hahn, EA ;
Bjordal, K ;
SpernerUnterweger, B ;
Gangeri, L ;
Bergman, B ;
WillemsGroot, J ;
Hanquet, P ;
Zittoun, R .
QUALITY OF LIFE RESEARCH, 1996, 5 (03) :309-320
[8]  
Bray F, 2018, CA-CANCER J CLIN, V68, P394, DOI [10.3322/caac.21492, 10.3322/caac.21609]
[9]   Urinary and sexual dysfunction in women after resection with and without preoperative radiotherapy for rectal cancer: a population-based cross-sectional study [J].
Bregendahl, S. ;
Emmertsen, K. J. ;
Lindegaard, J. C. ;
Laurberg, S. .
COLORECTAL DISEASE, 2015, 17 (01) :26-37
[10]   Anterior resection syndrome [J].
Bryant, Catherine L. C. ;
Lunniss, Peter J. ;
Knowles, Charles H. ;
Thaha, Mohamed A. ;
Chan, Christopher L. H. .
LANCET ONCOLOGY, 2012, 13 (09) :E403-E408